[iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen.

	Person	Schneider-Mergener, Jens (Adrenomed 201908– CEO before 3B BPharmaceuticals + Phavaris + Jerini)
	Person 2	Struckmeyer, Thomas (EW Group 202012– CEO at BioCheck BV before IdentiGEN)

You can read the latest version of the [LSG] Newsletter online at
http://www.life-sciences-germany.com/lsg-newsletter-021011-bbb6.html

This issue features:

ATAI Life Sciences – Adrenomed – RootCamp – Emergence Therapeutics – HTGF – Kaia Health – Chiesi Group – Debiopharm – Voluntis – Evotec – Rappta Therapeutics – 4SC – Novartis – Mesoblast – Lino Biotech – Jens Schneider-Mergener – BioChek Group – Thomas Struckmeyer – Bram Goorden – Sophia Genetics – Frank Misselwitz – Bayer – Semalytix – EuropaBio – Claire Skentelbery – Lead Pharma – Roche – Storm Therapeutics – Creoptix – oneservice – Losan Pharma – ipOcean – Synendos Therapeutics – Leaps by Bayer – Metagenomi – Beckman Coulter Life Sciences – m2p-labs GmbH – MorphoSys – Cherry Biolabs – BioNTech – Pfizer – Valneva – Xencor – Incyte – Cevec – Catalym – Vesalius Biocapital – Vifor Pharma – Angion – Biotecon Diagnostics

Record changed: 2020-12-11

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)